吴雄飞.加强肾脏病一体化治疗的基础和临床研究[J].第三军医大学学报,2008,30(02):91. [2]冯利平,张玲,钟玲,等.口服维生素E对维持性血液透析患者血清几种炎症因子水平的影响[J].第三军医大学学报,2007,29(08):733. FENG Li-ping,ZHANG Ling,ZHONG Ling,et al.Effect of vitamin E supplementation on microinflammation in maintenance hemodialysis patients[J].J Third Mil Med Univ,2007,29(18):733. [3]周晓娟,赵庆华,刘丽萍.维持性血液透析患者症状负担与生活质量相关性研究[J].第三军医大学学报,2013,35(05):464. Zhou Xiaojuan,Zhao Qinghua,Liu Liping.Correlation between symptom burden and quality of life in hemodialysis patients[J].J Third Mil Med Univ,2013,35(18):464. [4]李保华,胡长江,连军松,等.血液灌流联合血液透析治疗药物性肝损害的临床疗效观察[J].第三军医大学学报,2013,35(05):472. Li Baohua,Hu Changjiang,Lian Junsong,et al.Therapeutic efficiency of hemoperfusion combined with hemodialysis in treatment of drug-induced liver injury[J].J Third Mil Med Univ,2013,35(18):472. [5]李正胜,谢娟,黄波.尿毒营养膏治疗维持性血透营养不良的临床观察[J].第三军医大学学报,2010,32(21):2356. [6]陈丹燕,甘华,沈清,等.尿毒症血液透析患者Treg／Th17功能失衡影响血管钙化因子BMP-2表达的研究[J].第三军医大学学报,2011,33(21):2260. Chen Danyan,Gan Hua,Shen Qing,et al.Effect of Treg/Th17 cells dysfunction on expression of vascular calcification factor BMP-2 in uremia patients with dialysis[J].J Third Mil Med Univ,2011,33(18):2260. [7]赵国忠,陈晨,黄赞维,等.维持性血透患者心力衰竭危险因素的Logistic回归分析[J].第三军医大学学报,2008,30(19):1855. ZHAO Guo-zhong,CHEN Chen,HUANG Zan-wei,et al.Logistic regression analysis of risk factors for heart failure in hemodialysis patients[J].J Third Mil Med Univ,2008,30(18):1855. [8]吴亿,赵洪雯,王殿珍,等.不同途径中心静脉置管对血液透析并发症的影响[J].第三军医大学学报,2008,30(12):1206. WU Yi,ZHAO Hong-wen,WANG Dian-zhen,et al.Complications of central venous catheter insertion through 3 approaches in hemodialysis[J].J Third Mil Med Univ,2008,30(18):1206. [9]郭风玲,吴艳青,董巧荣,等.糖尿病肾病和慢性肾炎血液透析患者血压变异性的临床研究[J].第三军医大学学报,2014,36(03):302. [10]郭风玲,吴艳青,周瑾,等.缬沙坦对糖尿病肾病血液透析患者血压及血压变异性的影响[J].第三军医大学学报,2014,36(07):721. Guo Fengling,Wu Yanqing,Zhou Jin,et al.Effect of valsartan on blood pressure and blood pressure variability in diabetic nephropathy patients undergoing hemodialysis[J].J Third Mil Med Univ,2014,36(18):721.
